Skip to main content
Signal8

Lobe Sciences Ltd. (LOBEF)

Sector: Biotechnology

Industry: Biotechnology

Lobe Sciences Ltd. logo

Lobe Sciences Ltd.

OTC:LOBEFHealthcare
+10.81%$0.0355
CLOSED
Mkt Cap$10.93M
EV-
Float83.08M
O/S308.18M
VOL933 sh
$ Vol$33
RVOL0.01×
Inst Own-
Net Cash/Sh-
Dilution
Lobe Sciences Ltd. logoOTC:LOBEFClosed$0.0355+10.81%
Historical Data
DateOpenHighLowCloseVolume
Nov 16, 20260.03540.03550.03540.0355933
Nov 13, 20260.03260.03430.03200.032052,909
Nov 12, 20260.02910.03170.02910.0317615
Nov 11, 20260.02800.02880.02630.0271180,854
Nov 10, 20260.02820.02870.02600.028746,500
Nov 9, 20260.02870.02870.02610.028722,183
Nov 6, 20260.02430.02850.02110.0267268,233
Nov 5, 20260.02910.02910.02910.029115,000
Nov 4, 20260.02690.02690.02650.026823,113
Nov 3, 20260.02930.03000.02510.0300303,700
Nov 2, 20260.04010.04010.02660.027226,300
Oct 30, 20260.02910.03140.02900.031412,000
Oct 29, 20260.03750.03750.02890.0289120,100
Oct 28, 20260.03970.03970.03950.039522,897
Oct 27, 20260.03260.04050.03260.0405175,266
Oct 26, 20260.02750.02930.02640.0293229,956
Oct 23, 20260.02870.02870.02530.027547,216
Oct 22, 20260.03010.03140.02570.0268417,897
Oct 21, 20260.03550.03630.03150.0363291,977
Oct 20, 20260.03550.03550.03370.033735,000
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD).

Additionally, they engineer specialized devices aimed at enhancing the efficiency of drug administration. This organization, headquartered in Vancouver, Canada, underwent a name change from Greenstar Biosciences Corp. to Lobe Sciences Ltd. in November 2020.

Key Metrics
Market Cap$10.93M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 308.18M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeOTC
CountryCACA
IPO Date-
Shares Outstanding308.18M
Authorized Shares
Float83.08M
52-Week Range
$0.0207$0.1085
$0.0355(17th percentile)
Volume
Average Daily Volume109.18K
933 today vs 109.18K avg(-99%)

30d Avg

109.18K

60d Avg

100.20K

90d Avg

84.05K

Earnings
Dividend History
No dividend history available

Lobe Sciences Ltd. (OTC: LOBEF) traded at $0.0355 on Nov 16, 2026, up 10.81% from the previous close of $0.0320. 52-week range: $0.0207 to $0.1086. The company is in the Healthcare sector (Biotechnology).